National HealthCare Corp. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

384.79

380.82

373.10

371.82

367.92

334.93

288.63

Other Operating Income

0.00

Total Operating income

384.79

380.82

373.10

371.82

367.92

334.93

288.63

Raw Material Cost

100.80

238.27

92.87

94.53

86.39

84.53

79.44

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

233.24

233.18

226.53

228.13

234.32

213.40

180.08

Power Cost

0.00

Manufacturing Expenses

0.82

1.46

1.99

2.11

2.35

1.74

0.00

Selling and Distribution Expenses

7.59

6.25

10.40

9.29

8.29

8.86

9.28

Other Expenses

1.54

-1.11

1.41

-0.21

3.44

-2.39

0.02

Total Expenditure (Excl Depreciation)

357.80

468.03

345.88

331.95

365.77

284.64

269.01

Operating Profit (PBDIT) excl Other Income

-87.2

27.200000000000003

39.900000000000006

2.1

50.300000000000004

19.6

Other Income

4.24

4.66

5.13

4.08

4.83

6.76

8.19

Operating Profit (PBDIT)

42.99

-71.39

43.36

54.93

18.41

67.67

37.14

Interest

0.82

1.46

1.99

2.11

2.35

1.74

0.00

Exceptional Items

1.72

1.84

1.81

1.87

1.44

5.27

2.58

Gross Profit (PBDT)

272.22

131.39

269.22

266.32

270.09

239.78

199.84

Depreciation

11.77

11.16

11.02

10.98

11.44

10.62

9.34

Profit Before Tax

32.13

54.41

32.17

43.72

6.06

58.04

36.60

Tax

6.94

13.40

8.05

11.43

0.03

15.34

9.49

Provisions and contingencies

0.00

Profit After Tax

24.85

39.24

23.72

32.20

6.08

42.79

26.84

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

24.85

39.24

23.72

32.20

6.08

42.79

26.84

Share in Profit of Associates

0.00

Minority Interest

0.34

1.77

0.39

0.09

-0.05

-0.09

0.26

Other related items

0.00

Consolidated Net Profit

25.19

41.01

24.11

32.29

6.03

42.70

27.11

Equity Capital

0.00

Face Value

0.01

Reserves

1,068.77

1,052.98

1,021.90

1,004.89

980.16

983.47

945.82

Earnings per share (EPS)

1.58

2.5

1.52

2.07

0.39

2.73

1.73

Diluted Earnings per share

1.58

2.5

1.52

2.07

0.39

2.73

1.73

Operating Profit Margin (Excl OI)

7.01%

-22.9%

7.29%

10.72%

0.58%

15.01%

6.8%

Gross Profit Margin

11.41%

17.22%

11.57%

14.71%

4.76%

20.5%

15.92%

PAT Margin

6.46%

10.3%

6.36%

8.66%

1.65%

12.78%

9.3%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.05% vs 2.06% in Sep 2025

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -38.54% vs 70.12% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 151.05% vs -298.95% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -46.67% vs -25.00% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of National HealthCare Corp. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

384.79

240.00

144.79

60.33%

Other Operating Income

0.00

Total Operating income

384.79

240.00

144.79

60.33%

Raw Material Cost

100.80

79.79

21.01

26.33%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

233.24

0.00

233.24

Power Cost

0.00

Manufacturing Expenses

0.82

5.62

-4.80

-85.41%

Selling and Distribution Expenses

7.59

133.20

-125.61

-94.30%

Other Expenses

1.54

-0.51

2.05

401.96%

Total Expenditure (Excl Depreciation)

357.80

213.47

144.33

67.61%

Operating Profit (PBDIT) excl Other Income

26.99

26.54

0.45

1.70%

Other Income

4.24

-2.28

6.52

285.96%

Operating Profit (PBDIT)

42.99

54.74

-11.75

-21.47%

Interest

0.82

5.62

-4.80

-85.41%

Exceptional Items

1.72

-1.65

3.37

204.24%

Gross Profit (PBDT)

272.22

160.22

112.00

69.90%

Depreciation

11.77

30.48

-18.71

-61.38%

Profit Before Tax

32.13

16.98

15.15

89.22%

Tax

6.94

1.70

5.24

308.24%

Provisions and contingencies

0.00

Profit After Tax

24.85

17.58

7.27

41.35%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

24.85

17.58

7.27

41.35%

Share in Profit of Associates

0.00

Minority Interest

0.34

-2.29

2.63

114.85%

Other related items

0.00

Consolidated Net Profit

25.19

15.29

9.90

64.75%

Equity Capital

0.00

Face Value

0.01

0.00

Reserves

1,068.77

1,528.27

-459.50

-30.07%

Earnings per share (EPS)

1.58

0.21

1.37

652.38%

Diluted Earnings per share

1.58

0.21

1.37

652.38%

Operating Profit Margin (Excl OI)

7.01%

11.06%

0.00

-4.05%

Gross Profit Margin

11.41%

19.78%

0.00

-8.37%

PAT Margin

6.46%

7.32%

0.00

-0.86%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 38.48 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 1.05% vs 2.06% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 4.59% vs 26.95% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 2.52 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -38.54% vs 70.12% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 320.00% vs -78.57% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 3.88 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 151.05% vs -298.95% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 185.29% vs -58.66% in Dec 2024

Quarterly - Interest

Interest 0.08 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -46.67% vs -25.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -65.22% vs 2,200.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.01%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024